CBGV, an acronym for cannabigerivarin, is a component of the cannabis genome. CBGV is identified as a cannabinoid acid. However, it has no psychoactive effects, quite unlike THC.
Nevertheless, researchers are currently examining other possible health benefits that may be bestowed by marijuana strains high in CBGV. For instance, studies have shown that CBGV has potent anticonvulsant properties, so studies are ongoing to explore its potential as a medication of epileptic patients.
There are reports that landrace cannabis indica plants growing wildly in Nepal and Northwest India have high levels of CBGV.
According to researchers, the production of CBGV and other acids serves as a mechanism for survival. CBGV may offer insecticidal benefits to the parent plant, and may also make the plant more resistant to common diseases.
Cannabigerivarin doesn’t give any psychoactive effects upon ingestion, but the cannabinoid acid may potentiate the affinity of the body’s cell receptors to THC. It may also help with the metabolism of cannabidiol (CBD) within the body, and also by boosting the overall health benefits of cannabinoids.
It also seems that CBGV may potentiate the affinity of the body’s receptors to CBD. In other words, it helps cannabidiol to adhere to the body’s receptors. The conversion of CBGV to the usable CBD requires a thorough decarboxylation process. This is achieved by exposing the marijuana plant material to heat. Heating causes easy absorption of the cannabinoids and also eases its utilization by the human body. Research has shown that most cannabinoids are ineffective unless heated.